Sabril ^*

Sabril carries a significant and primary risk of causing permanent vision loss. This can range from mild vision field constriction, often called "tunnel vision," to more severe vision damage. The risk increases with higher doses and longer treatment duration. Because this side effect is irreversible, all patients prescribed Sabril must undergo regular, mandatory vision testing before and during their treatment to monitor for any changes. This risk is why the drug has a special safety program.

Sabril may begin to show effects at different times depending on the condition. For infantile spasms, some improvement and a reduction in spasm frequency may be seen within one to two weeks of starting the medication. For patients with refractory complex partial seizures, it may take longer, possibly several weeks to a few months, to see a significant reduction in seizure activity. Your doctor will monitor your progress closely.

Sabril treatment requires strict and specialized monitoring due to its risks. It is only available through a Risk Evaluation and Mitigation Strategy (REMS) program. This program mandates regular vision assessments by an ophthalmologist for all patients. These tests are required before starting the drug and periodically during treatment. This is to detect any potential vision loss as early as possible. Your doctor will also monitor for other side effects.

Sabril can cause weight gain in some patients who take it. This is considered a common side effect of the medication. The exact reason for the weight gain is not fully understood. It may be related to changes in the body's metabolism or an increase in appetite. If you are concerned about weight gain while taking Sabril, you should discuss it with your healthcare provider. They can offer advice on management.

Sabril is generally not a first-choice treatment for most types of seizures because of its serious side effect profile. However, Sabril is considered a first-line therapy specifically for infantile spasms, especially when associated with tuberous sclerosis complex. For refractory complex partial seizures, it is used as an adjunctive therapy only after several other medications have failed to control the seizures adequately. The decision to use it is always a careful balance of benefits and risks.

Sabril can cause drowsiness and dizziness, and alcohol can worsen these side effects. It is generally recommended to limit or avoid alcohol consumption while you are taking this medication. Combining alcohol with Sabril can impair your judgment and coordination, increasing the risk of accidents. You should speak with your doctor or pharmacist about whether any amount of alcohol is safe for you to consume during your treatment.

Sabril should be taken exactly as prescribed by your doctor. If you happen to miss a single dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, you should skip the missed one entirely. Do not take a double dose to make up for the one you missed. Taking too much Sabril can increase the risk of side effects.

Sabril should be stored safely in its original container at room temperature, which is between 68°F to 77°F (20°C to 25°C). Keep the medication away from areas with excess moisture, heat, or direct sunlight, so a bathroom is not an ideal place. It is also very important to keep Sabril and all other medications out of the reach of children and pets to prevent accidental ingestion.

Sabril may potentially cause harm to an unborn baby. Women who are pregnant or planning to become pregnant should discuss the risks and benefits thoroughly with their doctor. For some, continuing the medication to control seizures may be necessary. It is recommended that pregnant women taking this drug enroll in the North American Antiepileptic Drug (NAAED) Pregnancy Registry. This helps collect data to improve safety information for future patients.

Sabril can commonly cause feelings of tiredness, drowsiness, or fatigue. This is one of the most frequently reported side effects of the medication. Because of this, you should be cautious when driving, operating heavy machinery, or doing any other task that requires you to be alert. These effects may be stronger when you first start taking Sabril or when your dose is increased. They often lessen over time.

Sabril can cause permanent vision loss, so recognizing the signs is critical. The most common vision problem is a narrowing of the visual field, known as "tunnel vision." You might not notice it at first. Other signs can include blurry vision or a general decrease in visual acuity. It is essential to report any perceived change in your or your child's vision to your doctor immediately. Regular eye exams are mandatory.

Sabril is approved for use in specific pediatric populations. It is used as a primary treatment for infantile spasms in infants from one month to two years of age. It is also approved for children aged two years and older for refractory complex partial seizures, but only when other treatments have failed. The dosage for children is carefully calculated based on their body weight and is closely monitored by a physician.